Mental fatigue and cognitive functioning in patients presenting with non-enhancing gliomas - Summary - MDSpire

Mental fatigue and cognitive functioning in patients presenting with non-enhancing gliomas

  • By

  • Alice Neimantaite

  • Tomás Gómez Vecchio

  • Isabelle Rydén

  • Dima Harba

  • Asgeir S. Jakola

  • Anja Smits

  • March 8, 2025

  • 0 min

Share

Objective:

To analyze the association between mental fatigue and cognitive functioning prior to surgical treatment in patients with presumed lower-grade gliomas (LGG), highlighting its importance for clinical practice.

Key Findings:
  • 71 patients (70.3%) had a histomolecular diagnosis of IDH-mutated WHO grade 2 or 3 glioma, indicating a significant prevalence of this subtype.
  • Mental fatigue was assessed using MFI-20, while cognitive functioning was assessed using EORTC QLQ-C30, revealing a concerning relationship between the two.
  • Neuropsychological tests indicated various cognitive impairments among patients, underscoring the need for targeted interventions.
Interpretation:

Understanding the relationship between mental fatigue and cognitive functioning is crucial for patient counseling and rehabilitation planning in LGG, with implications for future research directions.

Limitations:
  • Cross-sectional design limits the ability to separate tumor effects from treatment effects, potentially confounding results.
  • Lack of established thresholds for clinically significant mental fatigue symptomatology may hinder the interpretation of findings.
Conclusion:

Further research is needed to clarify the interplay between mental fatigue and cognitive functioning in LGG patients, particularly prior to treatment, emphasizing the importance of longitudinal studies.

Original Source(s)

Related Content